tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

CVS Health price target lowered to $94 from $102 at UBS

UBS lowered the firm’s price target on CVS Health (CVS) to $94 from $102 and keeps a Buy rating on the shares. UBS says CVS sentiment is "weary," and that the key debate is what 2023/2024 earnings will be, as existing guidance of $8.70-$8.90 and $9.00 is perceived to be at risk from a potential earlier close of the Oak Street Health (OSH) deal, the MA rate notice and lower COVID revenues.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly

See Insiders’ Hot Stocks on TipRanks >>

Read More on CVS:

Disclaimer & DisclosureReport an Issue

1